 Tags:
cancer |
|
|
|
|
|
|
« Back 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 Next » |
|
»
The key to prevent CANCER's Recurrence is stress reduction
Published 2008-04-12
|
| 
A scientist shows that mind may indeed affect matter. After the surgical removal of a malignant tumor, the chance that cancer will re-appear in a different location of the body remains high. But new research from Tel Aviv University, in a bold new field called Psychoneuroimmunology, may prevent those cancer cells from taking root again -- and the key to the treatment is stress reduction.
|
»
Thalidomide provide more hope to women diagnosed with Ovarian CANCER
Published 2008-04-12
|
| 
Thalidomide, a drug blamed in the 1950s for causing birth defects, is now showing promise as a safe and effective treatment for women with recurrent ovarian cancer, according to a study led by a University of Minnesota Cancer Center researcher.
|
»
Highly targeted therapies Against Hormone-dependent Breast CANCER
Published 2008-04-12
|
| 
The identification of two cellular receptors that likely contribute to the genesis of hormone-dependent breast cancer points the way to new, highly targeted therapies against the disease, says a team led by scientists at Weill Cornell Medical College in New York City. The finding also helps explain how daily use of medicines such as aspirin might help keep these breast tumors at bay.
|
»
Eating cruciferous vegetables is associated with reduced risk for bladder CANCER
Published 2008-04-12
|
| 
A concentrated extract of freeze dried broccoli sprouts cut development of bladder tumors in an animal model by more than half, according to a report in the March 1 issue of Cancer Research.
|
»
Family of genes linked to the development of liver CANCER has been identified
Published 2008-04-12
|
| 
An interdisciplinary team of researchers at Stony Brook University Medical Center has identified a family of genes linked to the development of liver cancer. Principal Investigator Wadie F. Bahou, M.D., Professor of Medicine and Genetics, and colleagues discovered in a mouse model that the loss of one specific gene (Iqgap2) in this family causes Hepatocellular carcinoma (HCC). They also found that when another member of the gene family (Iqgap1) is turned on, a more aggressive form of the disease occurs.
|
»
Survival From Secondary Brain Tumors Correlated to Breast CANCER Subtypes
Published 2008-04-12
|
| 
Screening breast cancers for three receptors could help doctors predict the likely survival of patients with brain metastases. A study published in the open access journal Breast Cancer Research shows that patients with tumours that are negative for estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth receptor-2 (HER2) or that are HER2+/ER- appear to be most at risk from developing brain metastases. Survival is also correlated to the triple receptor status.
|
»
HPV DNA-based testing is more effective in detecting preCANCERous changes
Published 2008-04-10
|
| 
Adjustment of cervical cancer screening protocols as a woman ages may be cost-effective, regardless of whether she has been vaccinated against the human papillomavirus (HPV) that causes cervical cancer.
|
»
Anti-CANCER "warhead" targets the acidic signature of tumor cells
Published 2008-04-10
|
| 
Researchers in California report development of an anti-cancer "warhead" that targets the acidic signature of tumor cells in much the same way that heat-seeking missiles seek and destroy military targets that emit heat. These acid-seeking substances are not toxic to healthy cells, and represent a new class of potentially safer, more effective anti-cancer drugs, they say.
|
»
Human CANCERs Eliminated By cardiac hormones
Published 2008-04-10
|
| 
Hormones produced by the heart eliminated human pancreatic cancer in more than three-quarters of the mice treated with the hormones and eliminated human breast cancer in two-thirds of the mice, according to researcher David Vesely, a doctor at the James A. Haley Veterans Hospital in Tampa and a professor at the University of South Florida (USF).
|
»
New Test to Provide Better Care Of Breast CANCER Patients
Published 2008-04-10
|
| 
A new test that examines large sections of the sentinel lymph node for genes expressed by breast cancer could reduce the risk of recurrence and multiple surgeries, doctors say.
|
»
Combined hormone therapy may have adverse effect on breast CANCER detection
Published 2008-04-10
|
|
Combined hormone therapy appears to increase the risk that women will have abnormal mammograms and breast biopsies and may decrease the effectiveness of both methods for detecting breast cancer, according to a new report.
|
»
Gap in death rates from breast CANCER between black and white women has increased
Published 2008-04-10
|
| 
A new study from the American Cancer Society finds that while breast cancer death rates are decreasing for white women in every U.S. state, for African American women, death rates are either flat or rising in at least half the states. The study finds breast cancer death rates among African American women are decreasing in only 11 of 37 states with sufficient numbers for analysis and in the District of Columbia. In the rest, death rates are either flat (24 states) or actually increasing (two states: Arkansas and Mississippi).
|
»
New mechanism explains Resistance of Ovarian CANCERs To Platinum-based Chemotherapy
Published 2008-04-09
|
| 
A team of researchers led by Fred Hutchinson Cancer Research Center has identified a new mechanism that explains why some recurrent ovarian tumors become resistant to treatment with commonly used platinum-based chemotherapy drugs such as cisplatin and carboplatin. They describe their research online Feb. 10 in the journal Nature.
|
»
Experimental drug tested in other CANCERs might offer benefit in treating liver CANCER
Published 2008-04-09
»
New treatment for liver CANCER
Published 2008-04-09
|
|
Liver cancer specialists at Jefferson’s Kimmel Cancer Center in Philadelphia are beginning an 18-month study of a new treatment for liver cancer. The therapy entails injecting tiny beads that emit small amounts of radiation into the liver’s main artery while also blocking the blood supply feeding the cancer’s growth.
|
»
Tumor Blood vessels can develop from preCANCERous stem cells
Published 2008-04-09
|
|
Tumors require a blood supply to grow, but how they acquire their network of blood vessels is poorly understood. A new study here shows that tumor blood vessels can develop from precancerous stem cells, a recently discovered type of cell that can either remain benign or become malignant.
|
»
Patients Unresponsive To Standard Treatment May Benefit from New Bladder CANCER Therapy
Published 2008-04-09
|
| 
As many as half of patients with superficial bladder cancer do not respond to the standard first-line chemotherapy placed into the bladder, according to current multi-center outcomes data. When this happens, typically, their only option is surgical removal of the bladder. Now, researchers at the Herbert Irving Comprehensive Cancer Center of NewYork-Presbyterian Hospital and Columbia University Medical Center are investigating an FDA-approved metastatic breast-cancer drug called Abraxane® that may prove a safe and effective alternative to surgery for these patients.
|
»
Detection of HER2 Breast CANCER Improved by Chicken Antibodies
Published 2008-04-09
|
| 
Generations of mothers have served up chicken soup to remedy the common cold, but now the therapeutic fowl may find use in diagnosis as well. Researchers at the National Institute of Standards and Technology (NIST), the National Cancer Institute (NCI) and the scientific research firm SAIC recently showed how chicken antibodies may one day improve the detection of an aggressive form of breast cancer.
|
»
Drug-resistant tumours Targeted by new anti-CANCER agent
Published 2008-04-09
|
| 
A new anti-cancer agent that targets breast cancer can overcome resistance to cancer drugs, according to a new study. Many tumours that are initially responsive to chemotherapy can develop resistance to it, allowing the cancer to progress. Studies have shown that one of the key reasons for the development of resistance is a protein pump called P-glycoprotein. Resistant cancer cells express P-glycoprotein and this removes anti-cancer drugs from the cell before they are able to kill the cell.
|
»
The impact of breast CANCER on the financial status of patients and their families
Published 2008-04-09
|
| 
Canadian women diagnosed with early breast cancer lose, on average, more than a quarter of their typical income during the first 12 months after their diagnosis, according to a study published online February 26 in the Journal of the National Cancer Institute.
|
|
|
« Back 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 Next » |
